Editas Medicine, Inc. (EDIT) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$833
Total Return
-91.67%
CAGR
-39.17%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.41% |
| Median | -5.78% |
| Best | +162.29% |
| Worst | -57.19% |
| % of Windows Positive | 39.5% |
1-Year (252 Trading Days)
| Average | -31.60% |
| Median | -44.58% |
| Best | +226.53% |
| Worst | -88.83% |
| % of Windows Positive | 19.6% |
3-Year (756 Trading Days)
| Average | -83.20% |
| Median | -84.82% |
| Best | -43.87% |
| Worst | -95.96% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -98.66% |
| Average Drawdown | -82.97% |
| Drawdown Duration | 1190 Trading Days (Unrecovered) |
| Sortino Ratio | -0.14 |
| Calmar Ratio | -0.40 |
| CVaR (5%) | -11.05% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +35.61% (+105.95% ann.) | +$3561.00 | $0.00 | $0.00 | $0.00 |
| 2025 | +61.42% | +$6141.73 | $0.00 | $0.00 | $0.00 |
| 2024 | -87.46% | $8746.30 | $0.00 | $0.00 | $0.00 |
| 2023 | +14.21% | +$1420.50 | $0.00 | $0.00 | $0.00 |
| 2022 | -66.59% | $6659.13 | $0.00 | $0.00 | $0.00 |
| 2021 | -62.13% | $6213.09 | $0.00 | $0.00 | $0.00 |
| 2020 | +136.78% | +$13677.81 | $0.00 | $0.00 | $0.00 |
| 2019 | +30.15% | +$3015.38 | $0.00 | $0.00 | $0.00 |
| 2018 | -25.97% | $2596.81 | $0.00 | $0.00 | $0.00 |
| 2017 | +89.34% | +$8934.07 | $0.00 | $0.00 | $0.00 |
| 2016 partial | -10.82% (-11.88% ann.) | $1082.42 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | February 3, 2016 – February 19, 2020 | +45.82% | +9.78% | +$4582.42 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -25.55% | -96.55% | $2555.13 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +40.51% | +72.84% | +$4050.69 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +2.80% | +2.65% | +$279.51 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -67.18% | -69.36% | $6717.70 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -68.87% | -46.72% | $6887.10 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -28.35% | -17.75% | $2835.07 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.